Global Trust Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $794K | Hold |
863
| – | – | 0.3% | 60 |
|
|
2025
Q4 | $927K | Sell |
863
-476
| -36% | -$455K | 0.37% | 57 |
|
|
2025
Q3 | $1.02M | Sell |
1,339
-22
| -2% | -$16.4K | 0.46% | 51 |
|
|
2025
Q2 | $1.06M | Buy |
1,361
+197
| +17% | +$153K | 0.57% | 40 |
|
|
2025
Q1 | $961K | Sell |
1,164
-479
| -29% | -$399K | 0.59% | 40 |
|
|
2024
Q4 | $1.27M | Sell |
1,643
-25
| -1% | -$20.7K | 0.48% | 53 |
|
|
2024
Q3 | $1.48M | Buy |
1,668
+666
| +66% | +$599K | 0.55% | 44 |
|
|
2024
Q2 | $907K | Hold |
1,002
| – | – | 0.37% | 70 |
|
|
2024
Q1 | $780K | Sell |
1,002
-300
| -23% | -$214K | 0.32% | 76 |
|
|
2023
Q4 | $759K | Hold |
1,302
| – | – | 0.33% | 74 |
|
|
2023
Q3 | $699K | Hold |
1,302
| – | – | 0.33% | 74 |
|
|
2023
Q2 | $611K | Hold |
1,302
| – | – | 0.27% | 83 |
|
|
2023
Q1 | $447K | Sell |
1,302
-325
| -20% | -$110K | 0.21% | 97 |
|
|
2022
Q4 | $595K | Buy |
1,627
+450
| +38% | +$160K | 0.3% | 81 |
|
|
2022
Q3 | $381K | Sell |
1,177
-50
| -4% | -$15.8K | 0.2% | 100 |
|
|
2022
Q2 | $398K | Buy |
1,227
+525
| +75% | +$158K | 0.2% | 108 |
|
|
2022
Q1 | $201K | Hold |
702
| – | – | 0.08% | 172 |
|
|
2021
Q4 | $194K | Hold |
702
| – | – | 0.08% | 180 |
|
|
2021
Q3 | $162K | Hold |
702
| – | – | 0.07% | 180 |
|
|
2021
Q2 | $161K | Sell |
702
-1,700
| -71% | -$341K | 0.08% | 186 |
|
|
2021
Q1 | $449K | Buy |
2,402
+1,700
| +242% | +$333K | 0.25% | 96 |
|
|
2020
Q4 | $119K | Sell |
702
-51
| -7% | -$7.62K | 0.07% | 193 |
|
|
2020
Q3 | $109K | Buy |
753
+1
| +0.1% | +$155 | 0.07% | 166 |
|
|
2020
Q2 | $124K | Sell |
752
-3,150
| -81% | -$484K | 0.09% | 150 |
|
|
2020
Q1 | $540K | Buy |
3,902
+3,200
| +456% | +$440K | 0.42% | 63 |
|
|
2019
Q4 | $92K | Hold |
702
| – | – | 0.06% | 194 |
|
|
2019
Q3 | $79K | Sell |
702
-5,980
| -89% | -$666K | 0.05% | 178 |
|
|
2019
Q2 | $84K | Buy |
6,682
+5,980
| +852% | +$704K | 0.06% | 193 |
|
|
2019
Q1 | $91K | Sell |
702
-59
| -8% | -$7.17K | 0.07% | 183 |
|
|
2018
Q4 | $88K | Hold |
761
| – | – | 0.08% | 161 |
|
|
2018
Q3 | $82K | Buy |
761
+387
| +103% | +$38.7K | 0.06% | 191 |
|
|
2018
Q2 | $32K | Hold |
374
| – | – | 0.02% | 229 |
|
|
2018
Q1 | $29K | Hold |
374
| – | – | 0.02% | 227 |
|
|
2017
Q4 | $32K | Buy |
+374
| New | +$31.8K | 0.02% | 231 |
|
Other funds holding LLY
VCM
VPM
Global Trust Asset Management's LLY Position: Q1 2026 in Review
Global Trust Asset Management held its Eli Lilly (LLY) position steady in Q1 2026 at 863 shares worth $794K. The position accounts for 0.3% of the portfolio, ranked #60.
Global Trust Asset Management first reported a position in LLY in Q4 2017 and has held it in 34 quarters since. The position peaked at $1.48M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Global Trust Asset Management held 863 shares of Eli Lilly worth $794K as of Q1 2026.
- Global Trust Asset Management left its Eli Lilly share count unchanged in Q1 2026.
- Eli Lilly made up 0.3% of Global Trust Asset Management's portfolio in Q1 2026, its #60 holding.
- Global Trust Asset Management first reported a position in Eli Lilly in Q4 2017 and has held it in 34 quarters since.
- Global Trust Asset Management's Eli Lilly position peaked at $1.48M in Q3 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Global Trust Asset Management's 13F filing for Q1 2026, filed 23 Apr 2026.